Papers
1
Total Citations
26
H-Index
1
About
Kum Bae Kim is a leading figure in radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) and advanced treatment planning for hepatocellular carcinoma (HCC). His major contribution lies in the dosimetric comparison of cutting-edge technologies, particularly his seminal 2015 work comparing volumetric modulated arc therapy (RapidArc) with robotic SBRT (CyberKnife) for HCC. This highly cited study (26 citations) provided critical insights into optimizing SBRT delivery, demonstrating how different platforms affect tumor coverage and organ-at-risk sparing. Kim’s research has directly influenced clinical decision-making, helping radiation oncologists select the most effective technique for liver cancer patients. His work is notable for bridging the gap between technological innovation and practical patient outcomes, making him a respected authority in precision radiotherapy. With a career dedicated to refining treatment paradigms, Kim continues to shape the field through rigorous dosimetric analysis and a commitment to improving therapeutic ratios in challenging cancers.
Research Focus
Key Achievements
Top Papers
- 1